ArticleCureus2025
Persistent D-dimer Elevation in a Yolk Sac Germ Cell Tumor Without Thrombosis: A Potential Surrogate Marker of Tumor Necrosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
D-dimer is a widely used biomarker for thromboembolic events, but its role in oncology beyond clot detection remains underexplored. While transient elevation is common in cancer patients, persistent elevation without evidence of thrombosis is less well understood, particularly in germ cell tumors. We report the case of a 32-year-old male patient with a large anterior mediastinal yolk sac tumor who developed persistently elevated D-dimer levels despite multiple negative investigations for thrombosis, including CT pulmonary angiogram, ventilation-perfusion scan, and Doppler ultrasonography. Following debulking surgery, the patient showed clinical improvement and normalization of tumor markers, but D-dimer levels remained elevated at 2.4-2.5 mg/L. This case raises the possibility that persistent D-dimer elevation may reflect tumor necrosis or ongoing vascular remodeling rather than thrombosis or infection. If recognized, such a pattern could help clinicians avoid unnecessary anticoagulation and provide an adjunctive marker for residual tumor activity. D-dimer may have potential as a surrogate indicator of tumor dynamics in selected oncology settings. Further research is warranted to validate its prognostic or monitoring value in germ cell tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.